Skip to content

Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration

Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04970862
Enrollment
120
Registered
2021-07-21
Start date
2021-08-01
Completion date
2023-12-30
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adjacent Segment Degeneration, Adjacent Segment Disease

Keywords

Adjacent Segment Degeneration, reversion surgery

Brief summary

The purpose of this study was to investigate postoperative imaging changes and clinical symptom improvement in patients undergoing revision surgery for adjacent segment degeneration.

Interventions

PROCEDUREreversion surgery

reversion surgery

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* For patients undergoing revision surgery in adjacent segments due to S-ASD, the revision surgery is at least half a year from the first operation; * X-ray, CT and MRI examination data of the anterior and lateral extension of the lumbar spine were available within 1 month before surgery and at the last follow-up; * Follow-up for at least 2 years after revision;

Exclusion criteria

* Patients with history of congenital spinal deformity, spinal tumor, spinal tuberculosis.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS) scores of low back pain and leg pain2 years after revision surgeryVisual Analog Scale (VAS) scores of low back pain and leg pain
Japanese Orthopedic Association (JOA) score2 years after revision surgeryJapanese Orthopedic Association (JOA) score
Oswestry Disability Index (ODI)2 years after revision surgeryOswestry Disability Index (ODI)

Contacts

Primary ContactWeishi Li, M.D.
puh3liweishi@163.com(+86010)62017691-7011
Backup ContactZhuofu Li, M.D.
bjmulizhuofu@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026